Drugs / Pentavalent vaccine
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01349647 | May 2011 → Jul 2015 | lung cancer | Memorial Sloan Kettering Cancer Center | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT06748612 | Jan 2025 → Dec 2027 expected | poliomyelitis | International Centre for Diarrhoeal Disease Research, Bangladesh | Not yet recruiting | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT03801161 | Jun 2018 → Mar 2019 | — | International Centre for Diarrhoeal Disease Research, Bangladesh | Completed | No outcome recorded |
| — | NCT03000543 | Nov 2016 → Jun 2019 | — | International Centre for Diarrhoeal Disease Research, Bangladesh | Completed | No outcome recorded |
| Comparator or background therapy3 trials | ||||||
| Phase 2 | NCT04073459 Comparator | Nov 2019 → Apr 2020 | diphtheria, haemophilus infectious disease, hepatitis B virus infection, pertussis +2 | LG Chem | Unknown | No outcome recorded |
| Phase 2/3 | NCT06947499 Comparator | May 2025 → Feb 2028 expected | diphtheria, haemophilus infectious disease, hepatitis B virus infection, pertussis +2 | LG Chem | Active not recruiting | No outcome recorded |
| Phase 2/3 | NCT05457946 Comparator | Jul 2018 → Feb 2019 | diphtheria, haemophilus infectious disease, hepatitis B virus infection, pertussis +2 | LG Chem | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | pentavalent vaccine | “This is a pilot trial evaluating the safety and immunogenicity of a pentavalent vaccine for patients with small cell lung cancer (SCLC).” NCT01349647 ↗6“Pentavalent vaccine. It is a combination of five different antigens” NCT03000543 ↗ |
| Known as | wP-Penta | “Whole-cell pertussis pentavalent vaccine (wP-Penta): Each 0.5 ml dose contains diphtheria toxoid, Tetanus toxoid, whole cell pertussis, Hepatitis B surface antigen, Haemophilus...” NCT06748612 ↗ |
| Modality | Vaccine | “This study tests a vaccine, which is a substance injected under the skin which can cause an immune response.” NCT01349647 ↗ |
| Route | Subcutaneous | “This study tests a vaccine, which is a substance injected under the skin which can cause an immune response.” NCT01349647 ↗ |